How does INNPF compare to other cannabis stocks?

InnocanPharma (INNPF) has a market cap of $354.9M and trades at $5.07 per share. You can compare it against 5 sector peers and companies across the cannabis industry.

What are the closest competitors to INNPF?

The closest competitors to InnocanPharma by market capitalization include Cresco Labs (CRLBF), NewLake Capital Partners (NLCP), Akerna Corp (KERN). These companies operate in similar market cap ranges within the cannabis industry.

Is INNPF bigger than its peers?

InnocanPharma has a market capitalization of $354.9M. It ranks among Biotech cannabis companies by market cap, with 4 peers smaller by market cap.

Which cannabis stocks have better margins than INNPF?

InnocanPharma has a gross margin of 0.0%. Among its sector peers, 1 companies have higher gross margins.

Where can I compare INNPF with a specific cannabis stock?

You can use the comparison links on this page to compare InnocanPharma head-to-head with any cannabis stock listed on Cannabismarketcap. Each comparison shows price, valuation, financial metrics, and growth side by side.

Compare InnocanPharma (INNPF) With Other Cannabis Stocks

Head-to-head stock comparisons across price, valuation, financials, and growth metrics

Company

InnocanPharma (INNPF)

Price

$5.07

Change

0.00%

Market Cap

$354.9M

Sector

Biotech

Biotech Sector Peers

All Biotech cannabis companies sorted by market capitalization. Click any ticker to see a detailed head-to-head comparison.

Ticker	Name	Price	Change %	MCap	Revenue	P/S	Gross Margin
JAZZ	Jazz Pharmaceuticals	$178.55	-1.66%	$10.99B	$4.16B	2.6x	0.0%
CNVCF	BioHarvest Sciences	$5.71	+1.33%	$57.1M	$0	N/A	0.0%
ZYNE	Zynerba Pharmaceuticals	$1.30	+3.17%	$33.8M	$0	N/A	0.0%
XXII	22nd Century Group	$3.88	+1.97%	$2.0M	$18.1M	0.1x	36.3%
OVATF	Ovation Science	$0.02	0.00%	$623.3K	$0	N/A	0.0%

Top Matchups by Market Cap

Companies closest to InnocanPharma in market capitalization — the most meaningful head-to-head comparisons.

CRLBFMSO

Cresco Labs

MCap: $346.1M

$0.97-0.27%

Compare

NLCPREIT

NewLake Capital Partners

MCap: $370.3M

$15.43-1.09%

Compare

KERNAncillary

Akerna Corp

MCap: $376.3M

$6.27+24.64%

Compare

VFFLP

Village Farms International

MCap: $331.5M

$2.87-6.51%

Compare

CGCLP

Canopy Growth

MCap: $385.4M

$1.02-2.86%

Compare

Cross-Sector Comparisons

Top cannabis companies outside the Biotech sector. Compare across different business models and market segments.

SMGAncillary

Scotts Miracle-Gro

MCap: $3.54B

$60.96+0.96%

Compare

CURLFMSO

Curaleaf Holdings

MCap: $1.80B

$2.36+2.83%

Compare

TPBAncillary

Turning Point Brands

MCap: $1.73B

$90.62+0.69%

Compare

GTBIFMSO

Green Thumb Industries

MCap: $1.54B

$6.56+7.01%

Compare

IIPRREIT

Innovative Industrial Properties

MCap: $1.48B

$52.66-2.34%

Compare

Comparing INNPF in the Cannabis Market

InnocanPharma (INNPF) is a Biotech-sector cannabis company trading at $5.07 per share with a market capitalization of $354.9M. Among its Biotech peers, INNPF ranks #2 by market cap, with trailing twelve-month revenue of $0 and a gross margin of 0.0%. The stock has moved 0.00% in the current session, trading on the OTC exchange.

When comparing INNPF against other cannabis stocks, investors should consider key financial metrics including price-to-sales ratio (N/A), revenue growth (0.00% YoY), and balance sheet strength (cash of $0 vs. debt of $0). The comparison tables above allow you to evaluate InnocanPharma relative to 5 sector peers and leading companies across all cannabis sub-sectors, helping you identify which stocks offer better value, stronger growth, or more favorable risk profiles.

Frequently Asked Questions

How does INNPF compare to other Biotech stocks?+

InnocanPharma has a market cap of $354.9M, placing it among 6 companies in the Biotech sector. Its price-to-sales ratio is N/A and its gross margin is 0.0%. Use the table above to compare these metrics against every Biotech peer.

What is INNPF's biggest competitor?+

By market capitalization, the closest comparable company is Cresco Labs (CRLBF) with a market cap of $346.1M. Click the compare link to view a full head-to-head analysis.

Is INNPF overvalued compared to its peers?+

InnocanPharma trades at a P/S ratio of N/A. Compare this to sector peers in the table above to determine relative valuation. A lower P/S may indicate relative value, while a higher P/S may reflect growth expectations.

Which cannabis stock has better margins than INNPF?+

InnocanPharma has a gross margin of 0.0%. Among its Biotech peers, 1 companies report higher gross margins. See the Sector Peers table for a full ranking.

Can I compare INNPF to stocks in other cannabis sectors?+

Yes. The Cross-Sector Comparisons section above features top companies from sectors outside Biotech. You can click any company to see a full side-by-side comparison with INNPF covering price, valuation, financials, and growth metrics.

INNPF Stock Overview INNPF Financials INNPF News INNPF Investment Analysis Biotech Sector Stocks All Cannabis Stocks

Disclaimer: The comparison data on this page is for informational purposes only and does not constitute financial advice, investment recommendations, or an endorsement of any security. Cannabis stocks are highly volatile and subject to unique regulatory risks. Always conduct your own research and consult a licensed financial advisor before making investment decisions.Cannabismarketcap does not guarantee the accuracy or completeness of any data presented.

Compare InnocanPharma (INNPF) With Other Cannabis Stocks

Biotech Sector Peers

Top Matchups by Market Cap

Cross-Sector Comparisons

Comparing INNPF in the Cannabis Market

Frequently Asked Questions

Related Pages